Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol
Journal of Rheumatology, 09/14/09
Badesch DB et al. – This study reports longterm survival rates for patients with scleroderma-associated PAH treated with IV epoprostenol. Although comparisons to historical data should be made with caution, this study reports a better survival outcome than natural history data on patients with scleroderma-associated PAH.
Methods- One hundred two patients diagnosed with PAH in association with scleroderma who received epoprostenol
- 51 PAH patients from a subject population of 56 who received epoprostenol
- 46 patients from an initial population of 55 subjects on conventional therapy who received epoprostenol in the extension study
- Open-label epoprostenol
- Adverse events, survival, and dosing information collected
- Probabilities of survival during the first and second years for all subjects who received epoprostenol during the initial randomized controlled study or during the extension study were 0.71 and 0.52
- Measure remained constant at 0.48 during the third and fourth years
Related Articles
New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09
Relevance Score: 82%
Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells from Patients with Idiopathic Pulmonary Arterial Hypertension
Journal of Cardiovascular Pharmacology, 10/12/09
Relevance Score: 81%
Gilead Sciences Announces Plans for Phase IV Clinical Trial Evaluating First-Line Combination Therapy Versus Monotherapy in Pulmonary Arterial Hypertension
Gilead, 11/03/09
Relevance Score: 80%
Sequence Variants in BMPR2 and Genes Involved in the Serotonin and Nitric Oxide Pathways in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Relation to Clinical Parameters and Comparison with Left Heart Disease
Respiration, 10/20/09
Relevance Score: 80%
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 80%
Today in Heart Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Usefulness of Soluble Fms-like Tyrosine Kinase-1 as a Biomarker of Acute Severe Heart Failure in Patients With Acute Myocardial Infarction
The American Journal of Cardiology, 12/02/09
Electrical and mechanical dyssynchrony for prediction of cardiac events in patients with systolic heart failure
Heart, 12/02/09
Making sure services deliver for people with advanced heart failure: a longitudinal qualitative study of patients, family carers, and health professionals
Palliative Medicine, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


